Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$40.79 USD
+0.70 (1.75%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $40.91 +0.12 (0.29%) 5:26 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.85 | 1.47% |
Earnings Summary
For their last quarter, Xenon Pharmaceuticals (XENE) reported earnings of -$0.75 per share, missing the Zacks Consensus Estimate of -$0.72 per share. This reflects a negative earnings surprise of 4.17%. Look out for XENE's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.85 per share, reflecting a year-over-year decrease of 16.44%.
Earnings History
Price & Consensus
Zacks News for XENE
Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
XENE: What are Zacks experts saying now?
Zacks Private Portfolio Services